Quanterix Corporation Contract Liability (Deferred Revenue)
Quanterix Corporation (QTRX) had Contract Liability (Deferred Revenue) of $14.89 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Contract with Customer, Liability, Current $14.89M.
- 2026-03-31: Contract with Customer, Liability, Current $15.19M.
- 2025-12-31: Contract with Customer, Liability, Current $20.73M.
- 2025-09-30: Contract with Customer, Liability, Current $20.91M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.89M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $15.19M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $20.73M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $20.91M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $9.43M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $9.10M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $8.83M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $8.98M 10-Q · filed 2024-12-26 | |
| 2024-06-30 | $10.12M 10-Q/A · filed 2024-12-26 | |
| 2024-03-31 | $10.23M 10-Q/A · filed 2024-12-26 | |
| 2023-12-31 | $9.47M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $9.83M 10-K/A · filed 2024-12-26 | |
| 2023-06-30 | $10.42M 10-K/A · filed 2024-12-26 | |
| 2023-03-31 | $10.68M 10-K/A · filed 2024-12-26 | |
| 2022-12-31 | $8.64M 10-K/A · filed 2024-12-26 | |
| 2022-09-30 | $8.98M 10-K/A · filed 2024-12-26 | |
| 2022-06-30 | $12.16M 10-K/A · filed 2024-12-26 | |
| 2022-03-31 | $9.19M 10-K/A · filed 2024-12-26 | |
| 2021-12-31 | $6.36M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $5.74M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $6.15M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.42M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.42M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $3.79M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $5.02M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $5.44M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $4.70M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $4.91M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $5.19M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $5.48M 10-Q · filed 2019-05-10 | |
| 2019-01-01 | $5.39M 10-K · filed 2021-03-05 | $5.48M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.44M 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |